| Name | Cvs Pharmacy #00335 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 266 Route 44, Raynham, Massachusetts 02767 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (508) 824-1361 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new Tel Aviv University study finds that neonatal birthweights increase in direct proportion with the number of births of the mother in at least 30 percent of all cases. The study focuses on the risk of having large for gestational age infants, babies who clock in at higher than the 90th percentile for weight.
BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
Six outstanding contributors to the health and medical research industry are being recognised by Research Australia in its annual "Thank You" Day awards tomorrow (Friday 20 November 2009).
› Verified 7 days ago
| NPI Number | 1467551812 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY # 00335 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 266 New State Hwy, Raynham, MA 02767 |
| Phone Number | 508-824-1361 |
News Archive
A new Tel Aviv University study finds that neonatal birthweights increase in direct proportion with the number of births of the mother in at least 30 percent of all cases. The study focuses on the risk of having large for gestational age infants, babies who clock in at higher than the 90th percentile for weight.
BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
Six outstanding contributors to the health and medical research industry are being recognised by Research Australia in its annual "Thank You" Day awards tomorrow (Friday 20 November 2009).
› Verified 7 days ago
News Archive
A new Tel Aviv University study finds that neonatal birthweights increase in direct proportion with the number of births of the mother in at least 30 percent of all cases. The study focuses on the risk of having large for gestational age infants, babies who clock in at higher than the 90th percentile for weight.
BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
Six outstanding contributors to the health and medical research industry are being recognised by Research Australia in its annual "Thank You" Day awards tomorrow (Friday 20 November 2009).
› Verified 7 days ago
Cvs Pharmacy #00335 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 266 Route 44, Raynham, Massachusetts 02767 Phone: (508) 824-1361 | |
Cvs Pharmacy #00513 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 252 Broadway, Raynham, Massachusetts 02767 Phone: (508) 824-8621 | |
Walmart Pharmacy 10-2021 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 36 Paramount Dr, Raynham, Massachusetts 02767 Phone: (508) 822-7122 | |
Walmart Pharmacy 10-5448 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 160 Broadway, Raynham, Massachusetts 02767 Phone: (508) 692-6751 |